Did the histologic diversity of the primary tumor affect the patient's outcome in gastric cancer?

International Surgery

Volumn 91, Issue 6, 2006, Pages 308-315

  Nakamura, Kenji ^a   Ogoshi, Kyoji ^a   Makuuchi, Hiroyasu ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric cancer; Histological diversity; Prognosis

Indexed keywords

ARTICLE; CLASSIFICATION; GASTRECTOMY; HUMAN; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; STOMACH TUMOR; SURVIVAL RATE;

GASTRECTOMY; HUMANS; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 33846367050     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma. 13th edn. Tokyo, Japan: Kanehara Publishing, 1999
2. Kotanagi H, Fukuoka T, Shibata Y, Yoshioka T, Aizawa O, Koyama K. The clinical significance of regional variations in histologic differentiation within carcinoma of the colorectum. Surg Today 1993;23:407-411
3. Saito Y, Shiiba K, Ebina N, Matsuno S, Ouchi A. Histological grade of malignancy of the recurrent early gastric cancer after curative resection. Jpn J Gastroenterol Surg 1992;25:19-23
4. Kashimura H, Ikegami M. Clinicopathologic study of submucosal invasive gastric carcinoma-comparison of intramucosal and submucosal histology and study of mucin expression. Jpn J Gastroenterol Surg 1997;30:20-28
5. Goishi H, Tanaka S, Haruma K, Koike N, Shimizu T, Kimura T et al. Clinicopathologic analysis on differentiated type gastric carcinoma with invasion to muscularis propria-the significance of histologic grade at the deepest invasive portion of tumor, considering histologic heterogeneity. J Hiroshima Med Assoc 1997;50:331-336
6. Shimoyama M, Nunomura M, Saito N, Takiguchi N, Yanagisawa S, Sarashina H et al. Histological study in serosa invasive gastric cancer. Geka Chiryo 1993;69:584-585
7. Nakamura K, Ogoshi K, Makuuchi H. Focus on the histologic diversity in primary and lymph node lesions and the outcome of gastric cancer. J Exp Clin Cancer Res 2004;23:15-23
8. Jain S, Filipe NI, Hall PA, Wasseem N, Lane DP, Levison DA. Application of proliferating cell nuclear antigen (PCNA) immunostaining in gastric carcinoma. J Clin Pathol 1991;44:655-659
9. Mori M, Kakeji Y, Adachi Y, Moriguchi S, Maehara Y, Sugimachi K et al. The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer. Surgery 1993;113: 683-690
10. Nakazaki H, Mitomi T, Noto T, Ogoshi K, Hanaue H, Tanaka Y et al. Mosaicism in the expression of tumor-associated carbohydrate antigens in human colonic and gastric cancers. Cancer Res 1989;49:3662-9
11. Ikeda Y, Mori M, Kamakura T, Haraguchi Y, Saku M, Sugimachi K. Increased incidence of undifferentiated type of gastric cancer with tumor progression in 912 patients with early gastric cancer and 1245 with advanced gastric cancer. Cancer 1994;73:2459-2563
12. Saito A, Shimoda T, Nakanishi Y, Ochiai A, Toda G. Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Pathol Int 2001;51:165-171
13. Maehara Y, Emi Y, Baba H, Adachi Y, Akazawa K, Ichiyoshi Y et al. Recurrences and related characteristics of gastric cancer. Br J Cancer 1996;74:975-979
14. Goseki N, Takizawa T, Koike M. Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma. Gut 1992; 33:606-612
15. Mönig SP, Baldus SE, Collet PH, Zirbes TK, Bollschweiler E, Thiele J et al. Histological grading in gastric cancer by Goseki classification: correlation with histopathological subtypes and prognosis. Anticancer Res 2001;21:617-620
16. Nishikura K, Watanabe H, Ajioka Y, Hashidate H, Iwamatsu H, Ri K et al. Differentiated gastric adenocarcinoma with gastric phenotype-its new classification and histopathological characteristics. Stomach Intestine 1999;34:495-506
17. Mita T, Shimoda T. Risk factors for lymph node metastasis of submucosal invasive differentiated type gastric carcinoma: clinical significance of histological heterogeneity. J Gastroenterol 2001;36:661-668
18. Luinetti O, Fiocca R, Villani L, Alberizzi P, Ranzani GN, Solcia E. Genetic pattern, histological structure, and cellular phenotype in early and advanced gastric cancers: evidence for structure-related genetic subsets and for loss of glandular structure during progression of some tumors. Hum Pathol 1998;29:702-709
19. Mönig SP, Baldus SE, Hennecken JK, Spiecker DB, Grass G, Schneider PM et al. Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma. Histopathology 2001;39:597- 602
20. Imada T, Yamamoto Y, Fukuzawa K, Rino Y, Suda T, Moriwaki Y et al. Flow cytometric analysis of nuclear DNA heterogeneity in gastric cancer. Jpn J Clin Oncol 1997;27:221-226
21. Liu XP, Kawauchi S, Oga A, Tsushimi K, Tsushimi M, Furuya T et al. Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma. Jpn J Cancer Res 2002;93:291-295
22. Müller W, Schneiders A, Meier S, Hommel G, Gabbert HE. Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma. Br J Cancer 1996;74:759-765